All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AURA BIOSCIENCES, INC. Last Reported: 4/30/2024 Stock Symbol: AURA

Business Address

80 GUEST STREET

BOSTON , MA US 01235

Mailing Address

80 GUEST STREET

BOSTON , MA US 01235
Phone Number: (617)500-8864 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $41,063,000.00 $55,584,000.00 $47,732,000.00 $38,492,000.00 $121,582,000.00 $61,110,000.00 $53,849,000.00 $81,829,000.00 -- -- $17,393,000.00 $11,302,000.00 -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $5,625,000.00 $4,812,000.00 $4,178,000.00 $5,579,000.00 $7,871,000.00 $4,207,000.00 $5,510,000.00 $1,609,000.00 -- -- $1,043,000.00 -- -- -- --
Total Current Assets $231,794,000.00 $153,888,000.00 $166,211,000.00 $179,121,000.00 $196,702,000.00 $115,908,000.00 $127,669,000.00 $83,458,000.00 -- -- $18,455,000.00 -- -- -- --
Property Plant and Equipement $3,150,000.00 $4,856,000.00 $5,057,000.00 $5,167,000.00 $5,371,000.00 $5,475,000.00 $5,803,000.00 $4,442,000.00 -- -- $3,574,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $509,000.00 $685,000.00 $700,000.00 $623,000.00 $423,000.00 -- -- -- -- -- -- -- -- -- --
Total Assets $255,075,000.00 $179,766,000.00 $192,739,000.00 $206,019,000.00 $223,935,000.00 $143,147,000.00 $135,021,000.00 $90,704,000.00 -- -- $22,104,000.00 -- -- -- --
Accounts Payable $1,787,000.00 $1,490,000.00 $553,000.00 $1,055,000.00 $2,921,000.00 $1,724,000.00 $1,198,000.00 $1,736,000.00 -- -- $611,000.00 -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $29,227,000.00 $28,048,000.00 $26,302,000.00 $25,761,000.00 $28,352,000.00 $28,093,000.00 $5,930,000.00 $6,415,000.00 -- -- $2,741,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $539,000.00 $-134,000.00 $-223,000.00 $-45,000.00 $-72,000.00 $-147,000.00 $-128,000.00 -- -- -- -- -- -- -- --
Accumulated Deficit $-287,308,000.00 $-265,177,000.00 $-246,700,000.00 $-228,400,000.00 $-210,900,000.00 $-194,300,000.00 $-178,400,000.00 $-140,503,000.00 -- -- $-116,886,000.00 -- -- -- --
Total Stockholders' Equity $225,848,000.00 $151,718,000.00 $166,437,000.00 $180,258,000.00 $195,583,000.00 $115,054,000.00 $129,091,000.00 $-131,015,000.00 $-122,751,000.00 $-114,190,000.00 $-108,713,000.00 $-104,000,000.00 $-100,578,000.00 $-94,708,000.00 $-87,406,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $255,075,000.00 $179,766,000.00 $192,739,000.00 $206,019,000.00 $223,935,000.00 $143,147,000.00 $135,021,000.00 $90,704,000.00 -- -- $22,104,000.00 -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $65,232,000.00 $15,428,000.00 $29,524,000.00 $14,405,000.00 $42,238,000.00 $29,079,000.00 $9,510,000.00 $6,365,000.00 -- -- -- $2,850,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-84,991,000.00 $-20,488,000.00 $-39,720,000.00 $-19,444,000.00 $-60,295,000.00 $-42,682,000.00 $-13,816,000.00 $-23,623,000.00 -- -- -- $-3,631,000.00 -- -- --
Loss Before Income Taxes $-76,271,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-1.93 $-1.43 $-0.95 $-0.46 $-1.96 $-1.44 $-0.46 -- -- -- -- -- -- -- --
Weighted Average Shares Basic 39,620,036 38,185,197 37,855,533 37,784,282 29,937,228 29,273,577 29,232,661 -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-1.93 $-1.43 $-0.48 $-0.46 $-1.96 $-0.54 $-0.46 -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 39,620,036 38,185,197 37,820,104 37,784,282 29,937,228 29,273,577 29,232,661 -- -- -- -- -- -- -- --
Common Stock Shares Authorized 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 470,183,383 -- -- 232,697,999 -- -- -- --
Common Stock Shares Outstanding 49,350,788 38,216,717 38,086,606 37,800,102 37,771,918 29,283,285 29,266,848 442,717 -- -- 381,123 -- -- -- --
Common Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com